http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LT-3823960-T

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9db5428d6823098cb526c6c9db4c1ab5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 2019-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c2c78fe697878ced88d9bc1d787e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fcd76a0b3666c00f102c24f7a9f406b
publicationDate 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber LT-3823960-T
titleOfInvention ISOXAZOLES AS FXR RECEPTOR AGONISTS
priorityDate 2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408088710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9254

Total number of triples: 17.